Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;35(3):181.
doi: 10.2337/cd017-0025.

Basaglar

Affiliations

Basaglar

Cheyenne Newsome. Clin Diabetes. 2017 Jul.
No abstract available

PubMed Disclaimer

References

    1. Basaglar [prescribing information] Indianapolis, Ind., Eli Lilly/Boehringer Ingelheim, 2016
    1. Truven Health Analytics Micromedex Solutions [Internet]. Available from http://www.micromedexsolutions.com/micromedex2/librarian/CS/8685A3/ND_PR.... Accessed 1 March 2017
    1. Peters AL, Pollom RD, Zielonka JS, Carey MA, Edelman SV. Biosimilars and new insulin versions. Endocr Pract 2015;21:1387–1394 - PubMed
    1. U.S. Food and Drug Administration FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes. Available from https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm477734.htm. Accessed 1 March 2017
    1. Blevins TC, Dahl D, Rosenstock J, et al. . Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomised controlled trial (the ELEMENT 1 study). Diabetes Obes Metab 2015;17:726–733 - PubMed